Abstract
The effect of neoadjuvant chemoradiotherapy on the immune profile of pancreatic ductal adenocarcinoma: in-depth analysis of the PREOPANC-1 randomised controlled trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have